10/30/2007

EU approves use of implantable defibrillator

The US firm Boston Scientific reports that it has received the Conformité Européenne (CE) Mark for its Confient implantable cardioverter defibrillator (ICD), the company's first branded cardiac rhythm management device to treat sudden cardiac death. Containing wireless capability, the Confient ICD has been designed to reduce right ventricular pacing.

---

Product of the month

Radbook